CSTONE PHARMA-B (02616.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec30

GIC Private Limited increases holdings in Chihang Pharmaceutical-B

00:53

Dec8

Hu Zhengguo Increased Holdings in Chi-Medical

11:22

Basestone Pharmaceutical's Prguwa Inclusive in National Health Insurance Directory

04:23

Nov25

Chi-Med's Sugemalimab Approved for Use in NSCLC Patients with Specific Genetic Features

04:05

Nov18

Yang Jianxin Increased Holdings in CStone Pharmaceuticals

11:23

Nov14

00:02

Schedules & Filings

Schedules

Filings

Aug14

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 27.06 M, Net Income -147.86 M, EPS -0.1149

Mar27

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 81.41 M, Net Income -56.87 M, EPS -0.0445

Sep20

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 136.55 M, Net Income 8.435 M, EPS 0.0053

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More